Public listing · Acquire
Modern at-home allergy immunotherapy that replaces years of in-office shots for sale in Inc., CA · $2,899,611
Inc., CA·Online / Digital
- Asking price
- $2,899,611
- Cash flow
- $126,400UNKNOWN
- Revenue
- $2,200,000
- Multiple
- 22.94x
- CoC preview
- -18.7%
- DSCR preview
- 0.44x
Soft estimate · 30% down · 7.5% · 10yr
Same assumptions · not a Desk underwrite
Overview
This is a national telehealth platform focused on physician-guided, at-home allergy immunotherapy via a subscription model, helping patients access long-term, disease-modifying treatment without frequent in-office visits, while operating a fully compliant infrastructure licensed across all 50 states with integrated clinical, pharmacy, and technology workflows that support durable recurring revenue through multi-year …
Keep deals in one Desk
Save listings, set your buy-box (CoC + DSCR), and track NDAs — $99/mo.
Free to browse. Desk unlocks saves + deal tools.
Canonical path /listings/acquire/modern-at-home-allergy-immunotherapy-that-replaces-years-of-in-office-shots-cmtun50jw00rx7yjs2obx6pf2. Sourced from Acquire; we do not canonical to the board URL.